3SBio Arm to Obtain Commercialization Rights for RMX Biopharma's Paclitaxel Oral Solution

MT Newswires Live

2024/10/24

3SBio's (HKG:1530) subsidiary Shenyang Sunshine Pharmaceutical will obtain the exclusive commercialization rights of Shanghai RMX Biopharma's product of paclitaxel oral solution in Hong Kong and China, a Thursday Hong Kong bourse filing said.

Shenyang Sunshine will make an upfront payment to RMX Biopharma, a subsidiary of Shanghai Haihe Biopharma Research and Development, as well as milestone payments for sales and research and development.

The ongoing research, development and any related clinical and registration works will still be handled by RMX Biopharma.

The biopharmaceutical company's shares were down over 1% on Thursday's close.

Price (HKD): $6.20, Change: $-0.090, Percent Change: -1.43%

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2477214689"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2477214689\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2477214689?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-24 19:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2477214689","market":"sg","top_or_hot":-1,"title":"3SBio Arm to Obtain Commercialization Rights for RMX Biopharma's Paclitaxel Oral Solution","media":"MT Newswires Live","content":"<html><body><p> 3SBio's (HKG:1530) subsidiary Shenyang Sunshine Pharmaceutical will obtain the exclusive commercialization rights of Shanghai RMX Biopharma's product of paclitaxel oral solution in Hong Kong and China, a Thursday Hong Kong bourse filing said.</p><p>Shenyang Sunshine will make an upfront payment to RMX Biopharma, a subsidiary of Shanghai Haihe Biopharma Research and Development, as well as milestone payments for sales and research and development.</p><p>The ongoing research, development and any related clinical and registration works will still be handled by RMX Biopharma.</p><p>The biopharmaceutical company's shares were down over 1% on Thursday's close.</p><p>Price (HKD): $6.20, Change: $-0.090, Percent Change: -1.43%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3SBio Arm to Obtain Commercialization Rights for RMX Biopharma's Paclitaxel Oral Solution</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3SBio Arm to Obtain Commercialization Rights for RMX Biopharma's Paclitaxel Oral Solution\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2024-10-24 19:26</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> 3SBio's (HKG:1530) subsidiary Shenyang Sunshine Pharmaceutical will obtain the exclusive commercialization rights of Shanghai RMX Biopharma's product of paclitaxel oral solution in Hong Kong and China, a Thursday Hong Kong bourse filing said.</p><p>Shenyang Sunshine will make an upfront payment to RMX Biopharma, a subsidiary of Shanghai Haihe Biopharma Research and Development, as well as milestone payments for sales and research and development.</p><p>The ongoing research, development and any related clinical and registration works will still be handled by RMX Biopharma.</p><p>The biopharmaceutical company's shares were down over 1% on Thursday's close.</p><p>Price (HKD): $6.20, Change: $-0.090, Percent Change: -1.43%</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00BMPRXN33.USD","symbol_name":"NEUBERGER BERMAN 5G CONNECTIVITY \"A\" (USD) ACC","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2477214689","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2477214689","pubTimestamp":1729769201,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"3SBio's  subsidiary Shenyang Sunshine Pharmaceutical will obtain the exclusive commercialization rights of Shanghai RMX Biopharma's product of paclitaxel oral solution in Hong Kong and China, a Thursday Hong Kong bourse filing said.Shenyang Sunshine will make an upfront payment to RMX Biopharma, a subsidiary of Shanghai Haihe Biopharma Research and Development, as well as milestone payments for sales and research and development.The ongoing research, development and any related clinical and registration works will still be handled by RMX Biopharma.The biopharmaceutical company's shares were down over 1% on Thursday's close.Price : $6.20, Change: $-0.090, Percent Change: -1.43%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"688981":"中芯国际","IE00BMPRXN33.USD":"NEUBERGER BERMAN 5G CONNECTIVITY \"A\" (USD) ACC","BK4526":"热门中概股","IE00BMPRXQ63.HKD":"NEUBERGER BERMAN NEXT GENERATION CONNECTIVITY FUND \"A\" (HKDHDG) ACC","BK1161":"生物科技","BK1593":"医美概念股","BK4023":"应用软件","BK4585":"ETF&股票定投概念","BK4141":"半导体产品","BK4588":"碎股","01530":"三生制药","BK1583":"高瓴概念","LU0348723411.USD":"ALLIANZ GLOBAL HI-TECH GROWTH \"A\" (USD) INC","IE00BMPRXR70.SGD":"Neuberger Berman 5G Connectivity A Acc SGD-H","HKD":"尚乘数科"},"translate_title":"三生制药Arm将获得RMX Biopharma紫杉醇口服溶液商业化权利","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688981":0.7,"01530":0.9,"HKD":1},"content_text":"3SBio's (HKG:1530) subsidiary Shenyang Sunshine Pharmaceutical will obtain the exclusive commercialization rights of Shanghai RMX Biopharma's product of paclitaxel oral solution in Hong Kong and China, a Thursday Hong Kong bourse filing said.Shenyang Sunshine will make an upfront payment to RMX Biopharma, a subsidiary of Shanghai Haihe Biopharma Research and Development, as well as milestone payments for sales and research and development.The ongoing research, development and any related clinical and registration works will still be handled by RMX Biopharma.The biopharmaceutical company's shares were down over 1% on Thursday's close.Price (HKD): $6.20, Change: $-0.090, Percent Change: -1.43%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}